Master formulation and compounding records

Records are kept only in this browser; nothing is sent to ClinDose. Export a file to move them. Sign in to also save to your account.

Ingredients

Ingredient chips: FDA 503A categories and lists, 21 CFR 216.24, and NIOSH hazardous drugs. Check an ingredient in detail, including FDA shortages.

Equipment
Compounding steps
Quality control

Beyond-use date

Current: 180 days · Duration supported by the cited stability study for this formula, container, and storage.

Work out the BUD
Preparation
Dosage form
Storage

Beyond-use date

14 days

Refrigerator

  • Nonpreserved aqueous dosage form: 14 days, refrigerated.

USP <795> §10.4 (CNSPs requiring shorter BUDs), Table 4 (BUD limits by type of preparation)

Rules current as of the USP <795> and <797> revisions official November 1, 2023. Verify against the current official USP chapter before assigning a BUD.

References

Master formulation record: Atenolol oral suspension 2 mg/mL

Oral suspension · Oral · Nonsterile (USP <795>) · Batch 100 mL

Ingredients

IngredientRoleQuantity
Atenololactive0.2 g
Citric acid monohydratebuffer0.935 g
Sodium citrate dihydratebuffer1.632 g
Sweeteners (see the study)excipient
SuspendItvehicle q.s.

Equipment

  • Class A prescription balance or electronic balance
  • Mortar and pestle
  • Graduated cylinder

Quality control

  • Visual inspection: uniform appearance, no foreign matter
  • Final volume or weight checked

Packaging, storage, and BUD

Container: See the study · Storage: Refrigerator · BUD: 180 days

Basis: Duration supported by the cited stability study for this formula, container, and storage. Mota S et al. Pharmaceuticals (Basel). 2024;17(8):1052. PMC11359931

Labeling

Shake well. Store as directed. Discard after the beyond-use date.

References

  1. Mota S, Torres A, Quintas C, et al.. Characterization of Liquid Dosage Forms of Atenolol and Enalapril Maleate for Oral and Enteral Feeding Administration. Pharmaceuticals (Basel). 2024;17(8):1052. PMC11359931. https://pmc.ncbi.nlm.nih.gov/articles/PMC11359931/
Prepared by
Approved by
Date

Record contents follow the master formulation and compounding record sections of USP <795> and <797>; check your state board's requirements. For licensed clinicians. Use with clinical judgment.